Treatment
167 newsThe page turns scattered updates into useful context for people who live in Spain, visit Spain or follow Spanish affairs from abroad.
Spain reportedly expands CGM for basal-insulin diabetes care
A reported Spanish consensus would make continuous glucose monitoring routine for some type 2 diabetes patients using basal insulin. International guidance supports considering CGM for insulin-treated patients, but the Spanish figures still need the source document.
Europe narrows the cancer drug access gap, but Spain still faces delays
Austria and Switzerland led Europe in the use of newer cancer medicines in 2023, while Spain stayed in the middle. Approval and funding still do not guarantee that patients receive treatment quickly.
Young endocrinologists sharpen care for chronic hypoparathyroidism
More than 40 young specialists met in Madrid for Emerging Experts. The programme focused on chronic hypoparathyroidism and the decisions that go beyond calcium control.
Spanish doctors triple survival for multiple myeloma patients
Spanish patients with multiple myeloma now live three times longer than before, thanks to a wave of medical innovation and close cooperation between researchers and the pharmaceutical industry. Some even achieve functional remission.
Spain leaves osteoporosis patients exposed after a first fracture
Spain records about 285,000 fragility fractures each year. Specialists say too many eligible patients still miss treatment and follow-up after the first fracture.
How precise diagnosis is changing hematology care at a Madrid hospital
At Hospital Universitario Fundación Jiménez Díaz, specialists showed patients and trainees how blood counts, cellular studies, and genetic tests shape hematology care. The meeting also covered new treatments, transfusion support, research, and patient services.
October light loss puts vitamin D at risk in Spanish adults
Vitamin D levels may fall as October brings less useful sunlight, but available search results do not confirm that more than 60% of Spanish adults are affected. Testing matters because excess supplements can damage health.
Melanoma study identifies p38a as a target for stronger immunotherapy
Researchers in Barcelona identified p38a as a possible target in melanoma. Blocking the protein strengthened anti-PD-1 treatment in animal models and sometimes cleared tumours completely, but the findings remain preclinical.
Melanoma target may improve immunotherapy response
A Vall d'Hebron study points to p38a as a possible melanoma treatment target. Blocking the protein improved anti-PD-1 therapy in animal models, while a nine-gene profile may help identify tumours more likely to respond.
Europe approves a new single-dose antiviral for influenza
Roche has begun selling Xofluza in Spain. The oral antiviral blocks flu replication early and is taken in one dose within 48 hours.
Vall d'Hebron identifies a target linked to melanoma resistance
Vall d'Hebron researchers identified p38α as a possible target in melanoma treatment. Blocking the protein improved anti-PD-1 responses in experimental models and revealed a nine-gene signature linked to treatment outcomes.
Vall d'Hebron study points to p38α in melanoma resistance
Researchers at Vall d’Hebron found that blocking p38α improved anti-PD-1 treatment in melanoma models. The work also identified a nine-gene signature linked to treatment response and survival.
Meningitis demands urgent action when warning signs appear
Meningitis can worsen quickly, and its first signs may look ordinary. High fever, severe headache and neck stiffness need urgent medical assessment.
EU approves icotrokinra for moderate to severe psoriasis
The European Commission has approved ICOTYDE® for eligible psoriasis patients aged 12 and over. The once-daily oral peptide targets IL-23 directly and is backed by phase III data from about 2,500 participants.
Rheumatoid Arthritis Care Moves Toward Earlier Precision
More than 350 specialists met in Barcelona to discuss earlier rheumatoid arthritis diagnosis. Biomarkers and ultrasound are helping doctors spot disease sooner and tailor treatment for thousands of patients in Spain.
Spain faces intermittent shortages of transdermal hormone treatments
Lenzetto shortages are disrupting access to transdermal hormone treatments in Spain. Alternative patches are under pressure as regulators seek more supply and clinical guidance.
Early detection reshapes rheumatoid arthritis care in Spain
Around 20,000 new cases are diagnosed in Spain each year. Earlier detection and targeted therapies are helping doctors protect mobility and quality of life.
Spain's bowel disease care faces a nationwide equality test
GETECCU and ACCU España have presented a ten-point plan for inflammatory bowel disease care in Spain. The groups say access to specialist units and treatment still varies between autonomous communities.
CNIO identifies a weak stage before brain metastases cause symptoms
A six-year CNIO study found a short period when early brain metastases become vulnerable. Three drugs eliminated micrometastases in mice and human tissue before visible tumours formed.
CNIO identifies a brief window to attack hidden brain metastases
CNIO researchers found a short stage when early brain metastases are unusually vulnerable. Three drugs removed micrometastases in animal models before they developed into detectable tumours.
Blood test opens a new route to personalised cancer therapy
VHIO researchers found tumour neoantigens and responsive T cells in blood samples. The method could widen access to personalised immunotherapy when tumours are hard to biopsy.
CNIO finds a vulnerable window against brain metastasis
Spanish researchers found a brief stage when early brain metastases may respond to treatment. Three drugs cleared microscopic lesions in mice and human tissue, but clinical trials are still needed.
CNIO finds a drug target in early brain metastases
CNIO researchers found a short period when early brain metastases are unusually vulnerable. Three drugs destroyed micrometastases in laboratory models before they became detectable tumours.
Spain funds dual immunotherapy for metastatic colorectal cancer
Spain has begun funding its first dual immunotherapy for first-line treatment of metastatic colorectal cancer. The combination targets a rare tumour subtype and produced major gains over chemotherapy in a phase III trial.
Toledo psoriasis unit wins AEDV’s highest Cuderma rating
Auditors found that Toledo’s psoriasis unit met 33 basic indicators and 15 excellence indicators under the AEDV’s Cuderma programme. The review also examined patient education, follow-up and cooperation between medical teams.
Gedeon Richter puts daily osteoporosis care on a phone
Gedeon Richter has launched Tu Salud Ósea for people with osteoporosis in Spain. The app tracks treatment doses and brings exercise, food and disease information into daily care.
Respiratory viruses rise as schools and workplaces reopen
Covid, flu and colds are spreading more as schools and workplaces return to normal. The main trigger is renewed close contact, not the arrival of autumn itself.
SEEN calls for family screening to catch inherited high cholesterol early
Spain's endocrinologists want cascade screening for familial hypercholesterolaemia. Testing close relatives can uncover silent cases early and prevent years of exposure to dangerously high cholesterol.
Ozempic's Heart Benefit Still Defies Medical Explanation
A new analysis finds that semaglutide protects the heart in ways that weight loss alone cannot explain. Traditional risk factors account for no more than half of the reduction in cardiovascular disease seen in the international SELECT trial.
Spain weighs newborn screening for inherited high cholesterol
Spain is considering newborn screening for familial hypercholesterolaemia. A low-cost test could identify affected children and prompt checks for relatives before heart disease appears.
Restless legs syndrome can take more than a decade to diagnose
Restless legs syndrome may affect up to 10% of adults and around 4% of children and adolescents. In children, it is often mistaken for growing pains, and diagnosis can take more than a decade.
Personalized phage therapy saves a war-injured limb
A Spanish-led treatment cleared a stubborn battlefield infection. The patient avoided amputation and regained some elbow movement after receiving a bacteriophage alongside colistin.
Millions in Spain may have restless legs syndrome without a diagnosis
More than two million people in Spain may have restless legs syndrome. Up to 90% of cases may go undiagnosed while symptoms disrupt sleep and daily rest.
CRISPR restores part of a missing enzyme in cells linked to a rare disease
Spanish researchers corrected a faulty DNA reading signal in human cells. The change restored part of an enzyme needed for metabolism, though a possible treatment is still years away.
Why Spanish Alzheimer Researchers Are Turning to Myelin
Researchers in San Sebastián are testing whether damaged myelin helps drive Alzheimer's disease. The work could improve early detection and guide treatments that protect the brain's neural insulation.
Page 1 by 5